Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haim Werner

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
Cells|October 27, 2022
Long-Term IGF1 Stimulation Leads to Cellular Senescence via Functional Interaction with the Thioredoxin-Interacting Protein, TXNIPKarthik Nagaraj, Rive Sarfstein, Zvi Laron, et al.
Cells|November 28, 2019
Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer CellsRive Sarfstein, Karthik Nagaraj, Derek LeRoith, et al.
Endocrinology|September 4, 2004
Ataxia-telangiectasia mutated gene controls insulin-like growth factor I receptor gene expression in a deoxyribonucleic acid damage response pathway via mechanisms involving zinc-finger transcription factors Sp1 and WT1Limor Shahrabani-Gargir, Tej K Pandita, Haim Werner
Plos One|September 21, 2011
The mechanism of action of the histone deacetylase inhibitor vorinostat involves interaction with the insulin-like growth factor signaling pathwayRive Sarfstein, Ilan Bruchim, Ami Fishman, et al.
Frontiers in Oncology|July 23, 2016
Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection PathwaysHaim Werner, Rive Sarfstein, Derek LeRoith, et al.
Cells|November 13, 2020
Laron Syndrome Research Paves the Way for New Insights in Oncological InvestigationHaim Werner, Rive Sarfstein, Karthik Nagaraj, et al.
Trends in Endocrinology and Metabolism: TEM|June 3, 2008
IGF signaling defects as causes of growth failure and IUGRJürgen Klammt, Roland Pfäffle, Haim Werner, et al.
Endocrine Connections|January 18, 2014
Insulin receptor compensates for IGF1R inhibition and directly induces mitogenic activity in prostate cancer cellsDoron Weinstein, Rive Sarfstein, Zvi Laron, et al.
Expert Opinion on Biological Therapy|January 12, 2011
Controversies in the use of insulin analoguesHaim Werner, Doron Weinstein, Einat Yehezkel, et al.
Oncogene|December 14, 2004
Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signalingDana Ravid, Sharon Maor, Haim Werner, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
Cells|October 27, 2022
Long-Term IGF1 Stimulation Leads to Cellular Senescence via Functional Interaction with the Thioredoxin-Interacting Protein, TXNIPKarthik Nagaraj, Rive Sarfstein, Zvi Laron, et al.
Cells|November 28, 2019
Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer CellsRive Sarfstein, Karthik Nagaraj, Derek LeRoith, et al.
Endocrinology|September 4, 2004
Ataxia-telangiectasia mutated gene controls insulin-like growth factor I receptor gene expression in a deoxyribonucleic acid damage response pathway via mechanisms involving zinc-finger transcription factors Sp1 and WT1Limor Shahrabani-Gargir, Tej K Pandita, Haim Werner
Plos One|September 21, 2011
The mechanism of action of the histone deacetylase inhibitor vorinostat involves interaction with the insulin-like growth factor signaling pathwayRive Sarfstein, Ilan Bruchim, Ami Fishman, et al.
Frontiers in Oncology|July 23, 2016
Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection PathwaysHaim Werner, Rive Sarfstein, Derek LeRoith, et al.
Cells|November 13, 2020
Laron Syndrome Research Paves the Way for New Insights in Oncological InvestigationHaim Werner, Rive Sarfstein, Karthik Nagaraj, et al.
Trends in Endocrinology and Metabolism: TEM|June 3, 2008
IGF signaling defects as causes of growth failure and IUGRJürgen Klammt, Roland Pfäffle, Haim Werner, et al.
Endocrine Connections|January 18, 2014
Insulin receptor compensates for IGF1R inhibition and directly induces mitogenic activity in prostate cancer cellsDoron Weinstein, Rive Sarfstein, Zvi Laron, et al.
Expert Opinion on Biological Therapy|January 12, 2011
Controversies in the use of insulin analoguesHaim Werner, Doron Weinstein, Einat Yehezkel, et al.
Oncogene|December 14, 2004
Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signalingDana Ravid, Sharon Maor, Haim Werner, et al.
Pageof 12